Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial

M Werk, T Albrecht, DR Meyer, MN Ahmed… - Circulation …, 2012 - Am Heart Assoc
Background—Peripheral percutaneous transluminal angioplasty is fraught with a substantial
risk of restenosis and reintervention. A drug-eluting balloon (DEB) based on a novel coating …

Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial

G Tepe, B Schnorr, T Albrecht, K Brechtel… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: The purpose of this study was to evaluate the 5-year follow-up (FU) data of the
THUNDER (Local Taxan With Short Time Contact for Reduction of Restenosis in Distal …

Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study

JF McKinsey, T Zeller, KJ Rocha-Singh, MR Jaff… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives: The aim of this study was to assess the safety and effectiveness of directional
atherectomy (DA) for endovascular treatment of peripheral arterial disease (PAD) in …

A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and …

A Latib, A Colombo, F Castriota, A Micari… - Journal of the American …, 2012 - jacc.org
Objectives: The aim of this study was to evaluate the efficacy of drug-eluting balloons (DEB)
compared with paclitaxel-eluting stents (PES) for the reduction of restenosis in small …

Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical …

MD Dake, GM Ansel, MR Jaff, T Ohki, RR Saxon… - Journal of the American …, 2013 - jacc.org
Objectives: A prospective, multinational randomized controlled trial (RCT) and a
complementary single-arm study evaluated the 2-year safety and effectiveness of a …

Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options

JW Olin, CJ White, EJ Armstrong… - Journal of the American …, 2016 - jacc.org
The prevalence of peripheral artery disease (PAD) continues to increase worldwide. It is
important to identify patients with PAD because of the increased risk of myocardial infarction …

Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with …

J Lammer, T Zeller, KA Hausegger, PJ Schaefer… - Journal of the American …, 2013 - jacc.org
Objectives: The hypothesis that endovascular treatment with covered stents has equal risks
but higher efficacy than bare-metal stents (BMS) in long femoropopliteal artery disease was …

Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial

M Werk, S Langner, B Reinkensmeier, HF Boettcher… - Circulation, 2008 - Am Heart Assoc
Background—The success of percutaneous intervention in peripheral arterial disease is
limited by restenosis. The aim of the present pilot study was to evaluate a novel method of …

Classification and clinical impact of restenosis after femoropopliteal stenting

A Tosaka, Y Soga, O Iida, T Ishihara, K Hirano… - Journal of the American …, 2012 - jacc.org
Objectives: The purpose of this study was to investigate the relationship between
angiographic patterns of in-stent restenosis (ISR) after femoropopliteal (FP) stenting and the …

[HTML][HTML] Editor's choice–risk of major amputation following application of paclitaxel coated balloons in the lower limb arteries: a systematic review and meta-analysis of …

K Katsanos, S Spiliopoulos, U Teichgräber… - European Journal of …, 2022 - Elsevier
Objective There have been concerns about the long term safety of paclitaxel coated devices
in the lower limbs. A formal systematic review and meta-analysis of randomised controlled …